MVMaya Vijayaraghavan

Maya Vijayaraghavan

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Maya Vijayaraghavan has a total of 21 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Economic Evaluation of a Child Health Days Strategy to Deliver Multiple Maternal and Child Health Interventions in Somalia

    by Maya Vijayaraghavan, Aaron Wallace, Imran Raza Mirza, Raoul Kamadjeu, Robin Nandy, Elias Durry, Marthe Everard

    Introduction. Child Health Days (CHDs) are increasingly used by countries to periodically deliver multiple maternal and child health interventions as time-limited events, particularly to populations not reached by routine health services. In countries with a weak health infrastructure, this strategy could be used to reach many underserved populations with an integrated package of services. In this study, we estimate the incremental costs, impact, cost-effectiveness, and return on investment of 2 rounds of CHDs that were conducted in Somalia in 2009 and 2010. Methods. We use program costs and population estimates reported by the World Health Organization and United Nations Children’s Fund to estimate the average cost per beneficiary for each of 9 interventions delivered during 2 rounds of CHDs implemented during the periods of December 2008 to May 2009 and August 2009 to April 2010. Because unstable areas were unreachable, we calculated costs for targeted and accessible beneficiaries. We model the impact of the CHDs on child mortality using the Lives Saved Tool, convert these estimates of mortality reduction to life years saved, and derive the cost-effectiveness ratio and the return on investment. Results. The estimated average incremental cost per intervention for each targeted beneficiary was $0.63, with the cost increasing to $0.77 per accessible beneficiary. The CHDs were estimated to save the lives of at least 10 000, or 500 000 life years for both rounds combined. The CHDs were cost-effective at $34.00/life year saved. For every $1 million invested in the strategy, an estimated 615 children’s lives, or 29 500 life years, were saved. If the pentavalent vaccine had been delivered during the CHDs instead of diphtheria-pertussis-tetanus vaccine, an additional 5000 children’s lives could have been saved. Conclusions. Despite high operational costs, CHDs are a very cost-effective service delivery strategy for addressing the leading causes of child mortality in a conflict setting like Somalia and compare favorably with other interventions rated as health sector “best buys” in sub-Saharan Africa.


  • Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002

    by Maya Vijayaraghavan, Rebecca M. Martin, Nalinee Sangrujee, Geoffrey N. Kimani, Sammy Oyombe, Akpaka Kalu, Alfred Runyago, George Wanjau, Lisa Cairns, Steven N. Muchiri


  • Economic Evaluation of Measles Catch-Up and Follow-Up Campaigns in Afghanistan in 2002 and 2003

    by Maya Vijayaraghavan, Fabio Lievano, Lisa Cairns, Lara Wolfson, Robin Nandy, Amir Ansari, Anne Golaz, Taufiq Mashal, Peter Salama

    This paper assesses the cost-effectiveness of, and the return on the investment in, the 2002 catch-up and the 2003 follow-up measles campaigns in Afghanistan from the perspective of the donor. The catch-up campaign targeted nearly 12 million children aged between six months and 12 years, while the follow-up campaign targeted over five million children aged between 9 and 59 months. Both campaigns successfully vaccinated approximately 96 per cent of the respective target populations, and are expected to avert an estimated 301,000 measles deaths over the next 10 years. The average cost per dose of measles vaccine delivered was USD 0.40. The cost per death prevented is USD 23.6, assuming a case fatality rate of 10 per cent and a discount rate of three per cent. With more than 42,000 measles deaths avoided for every one million US dollars spent, the campaigns are an excellent public health investment for precluding childhood mortality in a country affected by a complex emergency.